Enfuvirtide Acetate
Product Overview
Key Features
In the year 2009, we initiated our business by offering Enfuvirtide Acetate. The provided chemical is basically demanded for enhancing the immune system of body in HIV patients. The offered chemical is processed under the utmost hygienic conditions by utilizing superior quality chemicals and pioneering methodology in conformance with international standards. Apart from this, we are offering this Enfuvirtide Acetate to our clients in different packaging options at marginal prices. Features: Excellent effectiveness Safe to use High solubility Precise composition Active Substance :Enfuvirtide is a 36 amino acid peptide corresponding to a region of gp41, the transmembrane subunit of HIV-1 envelope protein. Enfuvirtide belongs to the therapeutic class of fusion inhibitors and acts by binding to gp41 and impeding the conformational changes in gp41 necessary for fusion of the virus with the cell.This product is offered and sold in small quantities only and solely for uses reasonably related to privileged trials and studies for obtaining marketing authorization required by law (Bolar Exemption). JYM cannot be made liable for any infringement of intellectual property rights. It is the sole and only responsibility of the purchaser or user of this product to comply with the relevant national rules and regulations. Specification : Synonyms T20; Pentafuside Sequence : Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2 acetate salt Fields of Application : Human immunodeficiency virus type 1 (HIV-1) infection Enfuviritide is used in combination with other antiretroviral agents in therapy-experienced patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy.
Explore in hindi - एनफुविर्टाइड एसीटेट
Company Details
Shenzhen JYMed Technology Co., Ltd. (JYMed) founded in 2009, is an innovative pharmaceutical enterprise with independent intellectual property rights in R&D, manufacturing and commercialization of peptide products. There are two subsidiary companies of Shenzhen JX Bio Pharmaceutical Co., Ltd. and Hubei JX Bio Pharmaceutical Co., Ltd. It is initiative to establish the R&D technology platform for peptide products and sustained release pharmaceutical preparation of peptide and protein medicines by JYMed in China. The peptide products in R&D are in the forward position in China and aboard, while the technology is in the domestic leading position and international advanced level.
Our company has an excellent R&D team, management team and first-class expert consultant team consisting of professionals including doctors, masters, professors, researchers, senior engineers. Meanwhile, to maximally extend the R&D team by hiring top industry scientists to serve as guest researchers, commissioners, and technical consultants and strengthening technical cooperation with external scientific research units. It has established a good cooperative relationship with famous universities and research institutions such as Southwest University, School of Pharmaceutical Science, Sun Yat-Sen University, Hebei University, Research Institute of Tsinghua University, Southern University of Science and Technology, Shenzhen Technology University, and Shenzhen University.
The company has passed the certification of Shenzhen High-tech Enterprise and National High-tech Enterprise. As a domestic enterprise with the advantage of the industrialization of polypeptide APIs, it has achieved a major technological breakthrough in the industrialization of polypeptide APIs with extremely high technical difficulty. With high-quality product quality, the company carries out open R&D CRO services. The market network covers domestic and foreign markets. The cooperation customers are mainly domestic and foreign large-scale new drug R&D and production companies.
In recent years, JYMedhas been focusing on R&D and production of peptide. At the same time, the company also has been focusing on the development and industrialization. It has been continually increasing investment in high-end chemical drugs and biological drugs, striving for long-term business operations and develop in an all-round way to create a more prominent corporate competitive advantage.
The company is adhering to the enterprise spirit of A A A A A A A A A A A A A A A AcA A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A Tianjianzhishan, Tianyuanzhihe.A A A A A A A A A A A A A A A AcA A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A We are with a grateful heart and commit to providing reliable medical products for human health all the time. To work hard to become an influential and innovative company in the pharmaceutical industry.
Business Type
Exporter, Manufacturer, Supplier
Employee Count
400
Establishment
2009
Working Days
Monday To Sunday
Payment Mode
Telegraphic Transfer (T/T)
Seller Details
SHENZHEN JYMED TECHNOLOGY CO., LTD.
Name
Ms. Yancey Yang
AddressView on Map
Rm.1-107, Shenzhen Bio-Incubator Base, 10 Gaoxin C.Avc.1st, Nanshan District, Shenzhen, Guangdong, 518057, China
Report incorrect details
Related Products
Pharmaceutical Chemicals
Price - 120 INR (Approx.)
MOQ - 50 Kilograms/Kilograms
A. B. ENTERPRISES
Mumbai, Maharashtra
Acriflavine Hydrochloride Application: Pharmaceutical Industry
Price - 6500 INR (Approx.)
MOQ - 100 Kilograms/Kilograms
UNILAB CHEMICALS & PHARMACEUTICALS PVT. LTD.
Mumbai, Maharashtra
More Products From This Seller
Recommended Products
- Tradeindia
- Pharmaceutical Chemicals
- Enfuvirtide Acetate In Nanshan District